53123-88-9 Rapamycin AKSci C593
 
 
Loading Please Wait...
  C593    AKSci Reference Standard
Rapamycin, 98% (HPLC)
 
Sirolimus
23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine
IDENTITY
CAS Number:53123-88-9
MDL Number:MFCD00867594
MF:C51H79NO13
MW:914.17
SPECIFICATIONS & PROPERTIES
Min. Purity Spec:98% (HPLC)
Spectra:FT-IR, LCMS, HPLC, Polarimetry
Physical Form (at 20°C):White to off-white powder
Melting Point:183-194°C
Optical Rotation:-145 to -155° (c=0.472, MeOH)
Long-Term Storage:Store long-term at -20°C
DOT/IATA TRANSPORT INFORMATION
UN #:UN1993
Hazard Class:3; Flammable Liquid
Packing Group:III
A hazmat fee may apply, depending on the amount ordered.

BIOLOGICAL INFO
Solubility:DMSO: 20mg/mL; H2O: <1mg/mL; EtOH: 4mg/mL
Application(s):Specific Mammalian target of Rapamycin (mTOR) inhibitor
Form:Free Base

REVIEW
 An immunosuppressant drug used to prevent rejection in organ transplantation. Sirolimus inhibits the response to interleukin-2 (IL-2), and thereby blocks activation of T and B cells. In contrast, tacrolimus inhibits the secretion of IL-2. The mode of action of sirolimus is to bind the cytosolic protein FK-binding protein 12 (FKBP12) in a manner similar to tacrolimus. Unlike the tacrolimus-FKBP12 complex which inhibits calcineurin (PP2B), though, the sirolimus-FKBP12 complex inhibits the mammalian target of rapamycin (mTOR) pathway by directly binding the mTOR Complex1 (mTORC1).

REFERENCES
[1]Pagano, Thomas G.; Magnetic Resonance in Chemistry 2005, V43(2), P174-175; (2) Ley, Steven V.; Chemistry--A European Journal 2009, V15(12), P2874-2914.
[2] V?zina C, Kudelski A, Sehgal SN (October 1975). Rapamycin (AY-22,989), a new antifungal antibiotic. J. Antibiot. 28 (10): 721u20136. PMID 1102508.
[3] Pritchard DI (2005). Sourcing a chemical succession for cyclosporin from parasites and human pathogens. Drug Discovery Today 10 (10): 688-691. doi:10.1016/S1359-6446(05)03395-7. PMID 15896681.
[4] McAlister VC, Mahalati K, Peltekian KM, Fraser A, MacDonald AS. (June 2002). A clinical pharmacokinetic study of tacrolimus and sirolimus combination immunosuppression comparing simultaneous to separated administration.. Ther Drug Monit. 24 (3): 346-50. PMID 12021624.

GLOBALLY HARMONIZED SYSTEM (GHS)

Pictograms

Signal Word
Warning

Hazard Statements
H227

Precautionary Statements
P210; P280; P370+P378; P403+P235; P501

Current as of January 27, 2022

AKSci Reference Standards are high-purity, low-impurity compounds suitable for use as standards.


Download SDS

For research use only. Not for diagnostic or therapeutic use. Not for human use. AK Scientific, Inc. does not sell to individuals. If you are a first-time customer, please email for review at least two official business documents issued by your local jurisdiction, state/province, or country.


CATEGORIES
 APIs and Bioactives > Immunomodulators


PubChem